Recently, the optimal management of endocrine-responsive therapy early breast cancer in premenopausal women is controversial remains. Numerous benefits came from aromatase inhibitors beyond those of tamoxifen in postmenopausal women, but in premenopausal women their benefits among whom endocrine-responsive disease accounts for 62% of early breast cancers are unknown. It is still a combination of ovarian [...]
Archives for Breast
Morphological Types of Breast Cancer in Family Members and Multiple Primary Tumours: is Morphology Genetically Determined?
For a long time we have been assumed whether breast cancer morphology is genetically determined. As a background of the research, the author wanted to conduct a present study in line with our assumption. They used 10.2 million individuals data and more than 25,000 morphology-spesific breast cancer, which followed morphological types in familial cancers between [...]
